Live “attenuated” influenza virus vaccine protects animals against respiratory infections, including SARS-CoV-2

By | May 3, 2021
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19).